A duodenoscope that has a sterile disposable elevator component has been cleared for market and represents an important step in the fight against infection, according to the US Food and Drug Administration (FDA). The elevator component can be a breeding ground for infectious contamination if not cleaned properly, and that’s traditionally been a difficult process because it has so many parts.
Jeff Shuren, MD, director of the FDA’s Center for Devices and Radiological Health, in a press release called the approval a “major step toward lowering the risk of infection among patients who undergo procedures with these devices.”
Duodenoscopes are used in endoscopic retrograde cholangiopancreatography (ERCP) procedures; there are about 500,000 such procedures each year. They’re less invasive than traditional surgery in draining fluids from pancreatic and biliary ducts blocked by cancerous tumors or gallstones.The elevator part of the duodenoscope facilitates access to the bile and pancreatic ducts and is used to position endoscopic instruments during the procedure.
The FDA wants hospitals and other healthcare facilities to begin using devices with disposable componentsas soon as possible. The particular device the FDA approved is called the Pentax Medical Video Duodenoscope ED34-i10T2. PentaxMedical is a global corporation that manufactures endoscopic products.
The announcement does not come as a complete surprise. In August, the FDA asked that duodenoscope manufacturers and healthcare facilities transition to duodenoscopes with disposable components.“Disposable designs can simplify or eliminate the need for reprocessing of certain components, which may reduce between-patient duodenoscope contamination,” the agency said in its approval announcement.
The FDA has previously cleared duodenoscopes with removable endcap components.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Addressing Post-COVID Challenges: The Urgent Need for Enhanced Hospital Reporting Metrics
December 18th 2024Explore why CMS must expand COVID-19, influenza, and RSV reporting to include hospital-onset infections, health care worker cases, and ER trends, driving proactive prevention and patient safety.
Announcing the 2024 Infection Control Today Educator of the Year: Shahbaz Salehi, MD, MPH, MSHIA
December 17th 2024Shahbaz Salehi, MD, MPH, MSHIA, is the Infection Control Today 2024 Educator of the Year. He is celebrated for his leadership, mentorship, and transformative contributions to infection prevention education and patient safety.
Pula General Hospital Celebrates Clean Hospitals
December 16th 2024Learn how Pula General Hospital in Croatia championed infection prevention and environmental hygiene and celebrated Clean Hospitals Day to honor cleaning staff and promote advanced practices for exceptional patient care and safety.
Understanding NHSN's 2022 Rebaseline Data: Key Updates and Implications for HAI Reporting
December 13th 2024Discover how the NHSN 2022 Rebaseline initiative updates health care-associated infection metrics to align with modern health care trends, enabling improved infection prevention strategies and patient safety outcomes.